Companies: 10,795·Total market cap: $144.5T
Bioventus Inc.

Bioventus Inc.

BVSNASDAQHealthcare● Active
$9.01
$-0.03(-0.38%)
Market Cap$610091497
P/E Ratio
52W High$11.249
52W Low$5.81

Bioventus Inc.(BVS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BVS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.57B$0.57B$0.51B$0.51B$0.43B
Cost of Revenue$0.19B$0.19B$0.18B$0.18B$0.13B
Gross Profit$0.38B$0.39B$0.33B$0.33B$0.30B
Gross Margin %(computed)67.32%67.72%64.06%64.65%70.25%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.01B$0.02B$0.02B
G&A Expenses$0.00B$0.32B$0.30B$0.33B$0.00B
Total Operating Expenses$0.32B$0.40B$0.41B$0.50B$0.29B
Operating Income$0.06B($0.01B)($0.08B)($0.17B)$0.01B
Operating Margin %(computed)10.31%-2.09%-15.95%-32.66%2.80%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.03B$0.04B$0.04B$0.01B$0.00B
Income Before Tax$0.03B($0.05B)($0.12B)($0.19B)$0.01B
Income Tax Expense($0.00B)($0.01B)$0.00B($0.04B)($0.00B)
Net Income$0.02B($0.03B)($0.16B)($0.16B)$0.02B
Net Margin %(computed)4.00%-5.85%-30.49%-30.99%4.50%
Per Share & EBITDA
EPS (Basic)$0.34$-0.52$-2.49$-2.59$-0.15
Wtd Avg Shares0.07B0.07B0.06B0.06B0.05B
EBITDA$0.11B$0.04B($0.02B)($0.12B)$0.05B
EBITDA Margin %(computed)18.58%6.84%-4.50%-23.75%10.55%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Bioventus Inc.

关于Bioventus Inc.(BVS)损益表

Bioventus Inc.(BVS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BVS实现营收$0.57B,毛利润$0.38B(毛利率67.32%),净利润$0.02B(净利率4.00%)。

常见问题

BVS · 4 问

Bioventus Inc.(BVS)2025财年营收为$0.57B,同比down0.9%。

BVS revenueBVS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08